CN

Claudia Nardini

Chief Technical Officer

Enthera Pharmaceuticals

Milan, Lombardy


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Enthera Pharmaceuticals
Industry
pharmaceuticals
Employees
21.0
Seniority
C suite
Annual Revenue
800000.0
Total Funding
45980007.0
Latest Funding
Series A

Technologies

Outlook Amazon AWS Google Font API YouTube Vimeo Typekit Mobile Friendly Nginx WordPress.org AI

Keywords

pharmaceutical manufacturing biotech therapeutics autoimmune disorders disease-modifying treatments first-in-class biologics type 1 diabetes inflammatory bowel disease cell function biologics development monoclonal antibodies fusion proteins igfbp3 tmem219 apoptosis pathway clinical trials preclinical data lead candidate ent001 selective inhibitors therapeutic approaches stem cell capabilities undervalued conditions drug development investigational new drug marketing authorization treatment paradigm clinical candidates pancreatic beta cells intestinal structure restoration immune response modulation pharmaceutical innovation research & development targeted therapy medical need experimental therapies biotechnology investments clinical research patient care improvement novel treatment strategies clinical trial enrollment scientific collaboration investor engagement healthcare solutions advanced therapeutics medical breakthroughs chronic disease management patient outcomes therapeutic pipeline pharmaceuticals medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans